Pharmaceutical - Markets & Marketing, Research

Filter

Popular Filters

1 to 25 of 121 results

Health care and pharma execs optimistic about business conditions in 2015: Economist report

Health care and pharma execs optimistic about business conditions in 2015: Economist report

14-01-2015

More than half of pharma and healt care executives expect business conditions for their company to improve…

GlobalMarkets & MarketingPharmaceuticalPricingProductionResearch

EffRx partners with Andrus to expand footprint Russia and CIS

14-01-2015

Swiss drug delivery specialist EffRx Pharmaceuticals has signed an agreement with Moscow-based Andrus…

AndrusEffRx PharmaceuticalsMarkets & MarketingPharmaceuticalResearchRussia

New drugs and biosimilars to drive rheumatoid arthritis to $19.3 billion by 2023

New drugs and biosimilars to drive rheumatoid arthritis to $19.3 billion by 2023

13-01-2015

The launch of novel drugs and biosimilars will drive steady growth in the global rheumatoid arthritis…

AmgenAnti-Arthritics/RheumaticsEnbrelHumiraMarkets & MarketingPharmaceuticalResearchUSA

Global oncology market to hit $109 billion in 2020

Global oncology market to hit $109 billion in 2020

26-11-2014

Cancer, with a death toll exceeding that of AIDS (acquired immune deficiency syndrome), tuberculosis…

AvastinCelgene Corp.GlobalMarkets & MarketingMergers & AcquisitionsNovartisOncologyPharmaceuticalResearchRevlimidRoche

Oncology specialists say UK's capacity crisis is impacting patient care

Oncology specialists say UK's capacity crisis is impacting patient care

21-11-2014

A survey carried out by Swiss drug major Roche has shown that frontline staff believe patient care is…

Markets & MarketingOncologyPharmaceuticalResearchRocheUK

Threat or promise by 2020? The FT Global Pharmaceutical and Biotechnology Conference 2014

Threat or promise by 2020? The FT Global Pharmaceutical and Biotechnology Conference 2014

19-11-2014

The Pharma Letter reports from the FT Global Pharmaceutical and Biotechnology Conference 2014.

FT Global PharmaceuticalMarkets & MarketingPharmaceuticalResearchUK

Ulcerative colitis market to hit $4.2 billion by 2023

Ulcerative colitis market to hit $4.2 billion by 2023

13-11-2014

The ulcerative colitis market is set to grow from $2.7 billion in 2013 to $4.2 billion in 2023 in the…

Decision Resources GroupEntyvioGastro-intestinalsGlobalMarkets & MarketingPharmaceuticalRemicadeResearchXeljanz

UK health system spends most on AbbVie's Humira overall, according to HSCIC data on prescribing habits

UK health system spends most on AbbVie's Humira overall, according to HSCIC data on prescribing habits

12-11-2014

The Health & Social Care Information Centre has published its report on the prescribing habits of the…

HumiraLucentisMarkets & MarketingNational Health ServicePharmaceuticalResearchUKUnited Kingdom

China and Taiwan seek to cooperate in pharmaceutical industry

China and Taiwan seek to cooperate in pharmaceutical industry

11-11-2014

Pharmaceutical companies from the Chinese mainland and Taiwan convened for the first forum on cross-strait…

ChinaMarkets & MarketingPharmaceuticalResearchTaiwan

ScinoPharm and Nanjing King-friend team up to market new drugs in China

ScinoPharm and Nanjing King-friend team up to market new drugs in China

10-11-2014

ScinoPharm Taiwan and China’s Nanjing King-friend Biochemical Pharmaceutical (NKF) announced today…

Cardio-vascularChinaMarkets & MarketingNanjing King-friend BiochemicalPharmaceuticalRegadenoson InjectionResearchScinoPharma Taiwan

Israel’s pharma market will grow to over $2.3 billion by 2020, report

05-11-2014

Israel’s pharmaceutical market value will increase from around $1.9 billion in 2013 to $2.34 billion…

IsraelMarkets & MarketingPharmaceuticalResearchTeva Pharmaceutcal Industries

Report: Israel's pharma market set to reach $2.3 billion by 2020

Report: Israel's pharma market set to reach $2.3 billion by 2020

08-10-2014

Technological advances in the medical field, high expenditure on R&D and a robust economy provide the…

IsraelMarkets & MarketingPharmaceuticalPricingResearch

Ultra-rapid-acting insulin formulations will revolutionize type 1 diabetes market by 2019

Ultra-rapid-acting insulin formulations will revolutionize type 1 diabetes market by 2019

08-10-2014

Ultra-rapid formulations of the currently marketed rapid-acting insulin analogs have the clear potential…

AdociaBioChaperoneDiabetesFIAspGlobalMarkets & MarketingNovo NordiskPharmaceuticalResearch

Decline in sales rep access makes digital communications vital, says ZS report

Decline in sales rep access makes digital communications vital, says ZS report

24-09-2014

Digital communication channels are becoming increasingly important as cost pressures mean drug reps reduce…

BusinessMarkets & MarketingPharmaceuticalResearchUnited StatesUSA

New report debunks some common perceptions of R&D productivity

New report debunks some common perceptions of R&D productivity

08-09-2014

The 2014 edition of the Thomson Reuters CMR Pharmaceutical R&D Factbook, published today, contains some…

GlobalMarkets & MarketingPharmaceuticalRegulationResearch

Pharmaceuticals, a strategic sector for the UK government

Pharmaceuticals, a strategic sector for the UK government

28-07-2014

Britain’s pharmaceuticals sector, which includes AstraZeneca and GlaxoSmithKline, two drugmakers among…

AstraZenecaEconomy of the United KingdomFinancialGlaxoSmithKlineMarkets & MarketingPharmaceuticalResearchUK

Expert View: Has UK pharma lost its Euro-vision?

Expert View: Has UK pharma lost its Euro-vision?

23-07-2014

Former AstraZeneca serialization expert, Christoph Krähenbühl, demystifies the arguments around compliance…

EuropeEuropean UnionMarkets & MarketingMedicines verification infrastructurePharmaceuticalResearchUK

Fast growth forecast for dengue vaccine market

Fast growth forecast for dengue vaccine market

18-07-2014

Among the five major pharmaceutical markets (5MM: Brazil, India, Mexico, Singapore and Thailand), Brazil…

Asia-PacificBrazilMarkets & MarketingMexicoPharmaceuticalResearchTropical diseases

Cancer immunotherapy market set to grow to nearly $9 billion across major markets in 2022

Cancer immunotherapy market set to grow to nearly $9 billion across major markets in 2022

01-07-2014

The cancer immunotherapy market will experience considerable growth through 2022, increasing from $1.1…

AstraZenecaBristol-Myers SquibbEuropeJapanMarkets & MarketingMED14736Merck & ConivolumabOncologypembrolizumabPharmaceuticalResearchRocheUSAYervoy

Sanofi facing triple threat from Eli Lilly for diabetes treatment market space

Sanofi facing triple threat from Eli Lilly for diabetes treatment market space

26-06-2014

The imminent patent expiration of French pharma major Sanofi’s Lantus (insulin glargine) has opened…

BiosimilarsDiabetesdulaglutideEli LillyIDegLiraLantusLixiLanMarkets & MarketingNovo NordiskPharmaceuticalResearchSanofiToujeo

Third-party investigation confirms Takeda’s systematic involvement in CASE-J Study, but no data tampering

Third-party investigation confirms Takeda’s systematic involvement in CASE-J Study, but no data tampering

23-06-2014

Japan’s largest drugmaker Takeda Pharmaceuticals has updated on the third-party surrounding the results…

BlopressCardio-vascularJapanMarkets & MarketingPharmaceuticalResearchTakeda Pharmaceutical

1 to 25 of 121 results

Back to top